# Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)

> **NCT01173458** · — · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01173458
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-11
- **Final completion:** 2015-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173458, "Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01173458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*